A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Totus Medicines
Totus Medicines
BeOne Medicines
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
BeOne Medicines
BeOne Medicines
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Boundless Bio, Inc.